Medication info
Selmilsartan Tablets 40 mg (Telmisartan)

Selmilsartan Tablets 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201505088 · Approved 2015.07.27 · Insurance code 693901770

Summary

Main use
Treatment of essential hypertension; reduction of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medication has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medication be administered orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction of cardiovascular disease risk

  • Essential hypertension
View approved original text

This medication helps control blood pressure in patients with essential hypertension, reducing the strain on the heart and blood vessels. It is also applicable for high-risk diabetes patients who have a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack or who show evidence of end-organ damage, and cannot use ACE inhibitors. This medication is effective in reducing the risk of death from myocardial infarction, stroke, and cardiovascular diseases. Therefore, it is used for both blood pressure control and reduction of cardiovascular disease risk.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medication has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medication be administered orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients with allergies to this medication or its ingredients, pregnant or breastfeeding women, patients with severe liver diseases or biliary excretion disorders, patients with certain hereditary angioedema, or those with severe kidney impairment. Elderly patients, patients with hyperkalemia, patients with mild to moderate liver diseases, patients with heart valve diseases, gastrointestinal diseases, and renal artery hypertension should use this medication with caution. When taking this medication, various side effects such as infections, blood abnormalities, hyperkalemia, hypoglycemia, neurological symptoms, heart and vascular problems, respiratory and gastrointestinal issues, liver dysfunction, skin rash, muscle pain, and kidney impairment may occur; if any abnormal symptoms arise, individuals should consult a healthcare professional immediately. Particularly, serious side effects such as angioedema, hyperkalemia, renal dysfunction, shock, interstitial pneumonia, and rhabdomyolysis may occur, requiring careful attention. Patients with impaired kidney function should have serum potassium and creatinine levels regularly checked, and those with reduced blood volume or sodium may be at risk of hypotension; thus, these should be replenished before administration. It is advisable to refrain from taking this medication for 24 hours before surgery. The effect may be increased when used with other antihypertensive agents, and there is a greater risk of worsening kidney function, hyperkalemia, etc. when combined with certain medications; consult a physician. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should avoid taking it or stop breastfeeding. The safety and efficacy of this medication in children under 18 have not been established and are not recommended. Elderly patients should be carefully administered as there is a risk of stroke due to excessive blood pressure lowering. In case of overdose, symptoms such as hypotension, tachycardia, dizziness, and acute renal failure may occur, and immediate appropriate treatment is required. This medication should be kept out of reach of children, should not be transferred to another container, and should be opened just before taking it. This medication contains sorbitol and should not be used by patients with fructose intolerance. Caution is needed when driving or operating machinery due to the risk of dizziness or fainting caused by this medication.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 114 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • fainting
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal bloating
  • vomiting
  • abdominal discomfort
  • dry mouth
  • dysgeusia
  • liver dysfunction
  • liver disorders
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • kidney disorders
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • weakness
  • feeling of hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • angioedema
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • symptoms resembling anaphylaxis
  • interstitial pneumonia
  • rhabdomyolysis
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • decreased appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dyspepsia
  • cough
  • abdominal pain
  • decreased appetite
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • dizziness
  • acute renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Thus, to maintain the effectiveness of the drug, it is important to avoid direct sunlight and not to place it in excessively hot or cold places.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.